Evotec breaks ground on Toulouse biologics manufacturing facility
Evotec SE has officially launched the construction of its J.POD biologics manufacturing facility at its Campus Curie in Toulouse, France.
Archives for September 19, 2022
Polyplus extends portfolio designed to support mRNA development
Polyplus, a French supplier focused on advanced biologic and cell and gene therapy production, is continuing to build out its mRNA support portfolio.
bluebird bio gets green light for Skysona gene therapy in the US
The US Food and Drug Administration (FDA) has granted Accelerated Approval for bluebird bio’s Skysona (elivaldogene autotemcel), also known as eli-cel, to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active...
MeiraGTx unveils Ireland’s first commercial-scale gene therapy manufacturing site
MeiraGTx has formally opened its new GMP gene therapy manufacturing operations in Shannon, Ireland.